Article: Nasal spray puts an end to allergies; Good Health.

Byline: ROGER DOBSON

A NASAL spray that is designed to prevent allergic reactions could revolutionise treatment for millions of patients.

Unlike drugs that treat the symptoms of hay fever and other allergic reactions suffered by ten million people in the UK, the compound has been developed to block the reaction before it gets started.

The drug, known as R112, used by 319 patients on a clinical trial that finishes in three weeks, is said to be the first developed to tackle the root cause of allergic reactions.

The same approach may work for asthma, too, and development work is under way on a similar drug.

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!